|
Mar 29
|
Investing in Corcept Therapeutics (NASDAQ:CORT) five years ago would have delivered you a 114% gain
|
|
Mar 27
|
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
|
|
Mar 25
|
Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?
|
|
Mar 22
|
Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?
|
|
Jan 29
|
Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
|
|
Jan 29
|
Corcept Appoints Roberto Vieira as President, Oncology
|
|
Jan 9
|
Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024
|
|
Jan 8
|
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program
|
|
Jan 4
|
Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains?
|
|
Dec 29
|
Corcept loses patent spat against Teva, shares tumble
|
|
Dec 29
|
UPDATE 2-Corcept loses patent spat against Teva, shares tumble
|
|
Dec 24
|
Corcept Therapeutics Inc's Chief Development Officer Sells Shares
|
|
Dec 8
|
Here's Why Corcept Therapeutics (CORT) is a Strong Momentum Stock
|
|
Dec 7
|
Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?
|
|
Dec 7
|
Insider Sell: Joseph Lyon of Corcept Therapeutics Inc (CORT) Sells 5,000 Shares
|
|
Dec 1
|
Why Is Corcept (CORT) Up 0.7% Since Last Earnings Report?
|
|
Nov 4
|
Insider Sell: Chief Accounting Officer Joseph Lyon Sells 5,000 Shares of Corcept Therapeutics Inc
|
|
Nov 2
|
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
Corcept (CORT) Beats on Q3 Earnings, Raises '23 Sales View
|
|
Nov 1
|
Corcept Therapeutics Inc (CORT) Reports 22% Revenue Increase in Q3 2023
|